Enjoy complimentary customisation on priority with our Enterprise License!
The orphan drugs market size is forecast to increase by USD 146.1 billion at a CAGR of 11.62% between 2023 and 2028. The market is witnessing significant growth due to several key drivers. The powerful pipeline and recent approvals of novel therapies, particularly in the oncology therapy area, are fueling market expansion. Immunomodulators, biologics, and non-biologics are witnessing considerable demand, especially for the treatment of non-life-threatening diseases. Strategic collaborations, partnerships, and mergers and acquisitions among industry players are also contributing to market growth. However, challenges such as the delay in diagnosis and the high cost of these specialized treatments remain significant barriers. The report further highlights trends in outpatient hospital visits, clinical research, and the increasing prevalence of hematology, neurology, endocrinology, and immunotherapy indications.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.